Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Bear markets test retirement portfolios. This piece explains how risk parity may influence drawdowns and resilience, plus practical steps for retirees.
28,208 articlesA long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Investors are eyeing a renewed push for a classic dividend king as a robust oncology portfolio and resilience in earn...
A leading Bitcoin miner buys Cipher Mining's stake in three Texas sites, adding 4.4 EH/s and 120 MW to its fleet. The...
Sunrun’s Thursday rally followed a robust first-quarter report, highlighting strong revenue growth and a surge in ene...
Silicon Valley is fueling a defense tech surge, reshaping the investment landscape. This piece identifies five stocks...
A growing investing approach aims to fund car replacements with a dividend-driven portfolio, potentially ending auto ...
A tiny island nation shows that collective effort can outpace size. The legend cape verde: island offers practical mo...
When a smart-home name rallies, traders pay attention. This piece breaks down why resideo technologies stock popped o...
The United States faces a thinner fiscal buffer as debt climbs to $39 trillion, now taller than annual GDP. A top eco...
MicroStrategy sold 32 Bitcoin for about $2.5 million, the company’s first crypto cash-out since 2022. With Bitcoin ar...
A two-day pension fund rebalance could move about $30 billion of U.S. stocks, posing near-term volatility but often a...
Mark Cuban is reviving the debate over wage inequality by urging companies to grant stock to every worker. His pitch ...